At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Innovative Interventions for Smoking Cessation: Comparison of Very Low Nicotine Content Cigarettes Plus Nicotine Patch; Very Low Nicotine Content Cigarettes Alone or Nicotine Patch Alone
In Brief
A Phase 2 clinical trial evaluating Nicotine Patch, VLNC Cigarette, and 1 other intervention for Tobacco Use Disorder. Completed, enrolled 235 participants across 2 sites.
Detailed Summary
The purpose of this study is to evaluate the effect of a combination of the 21 mg nicotine patch and very low nicotine content (VLNC) cigarettes compared to 21 mg nicotine patch only and very low nicotine content cigarette only on abstinence, time to relapse and toxicant levels. The study will determine if adding nicotine replacement medication to the very low content cigarettes (VLNC) will augment treatment compared to nicotine patch only or to very low nicotine content cigarettes only.
Study Details
Timeline
Interventions
21 mg
Cigarette where the tobacco contains \<0.1 mg of nicotine yield.
21 mg nicotine patch plus use of cigarette with tobacco containing \<0.1 mg nicotine yield.